Home Healthcare IT Cancer Stem Cell Market Size, Share & Growth Report | 2033

Cancer Stem Cell Market Size, Share & Trends Analysis Report By Method of Action (Targeted Cancer Stem Cells, Stem Cell-Based Cancer Therapy), By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI20DR
Last Updated : December 19, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cancer Stem Cell Market Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    1. Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    4. U.S.
      1. By Method of Action
        1. Introduction
          1. Method of Action By Value
        2. Targeted Cancer Stem Cells
          1. By Value
        3. Stem Cell-Based Cancer Therapy
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    4. U.K.
      1. By Method of Action
        1. Introduction
          1. Method of Action By Value
        2. Targeted Cancer Stem Cells
          1. By Value
        3. Stem Cell-Based Cancer Therapy
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    4. China
      1. By Method of Action
        1. Introduction
          1. Method of Action By Value
        2. Targeted Cancer Stem Cells
          1. By Value
        3. Stem Cell-Based Cancer Therapy
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    4. UAE
      1. By Method of Action
        1. Introduction
          1. Method of Action By Value
        2. Targeted Cancer Stem Cells
          1. By Value
        3. Stem Cell-Based Cancer Therapy
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Method of Action
      1. Introduction
        1. Method of Action By Value
      2. Targeted Cancer Stem Cells
        1. By Value
      3. Stem Cell-Based Cancer Therapy
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    4. Brazil
      1. By Method of Action
        1. Introduction
          1. Method of Action By Value
        2. Targeted Cancer Stem Cells
          1. By Value
        3. Stem Cell-Based Cancer Therapy
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Cancer Stem Cell Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Advanced Cell Diagnostics Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Celgene Corp.
    3. Gamida Cell,
    4. Silicon Biosystems
    5. ViaCyte Inc.
    6. Merck KGaA
    7. Thermo Fisher Scientific, Inc
    8. AbbVie, Inc
    9. Bionomics
    10. Propanc Biopharma
    11. Lonza
    12. Menarini Group
    13. Miltenyi Biotec
    14. PromoCell GmbH
    15. MacroGenics, Inc
    16. Mereo BioPharma
    17. Irvine Scientific
    18. Sino Biological Inc
    19. BioTime Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global stem cells market size was estimated at USD 11.89 billion in 2021 and is estimated to reach an expected value of USD 31.95 billion by 2030 at a CAGR of 11.6% through the forecast period (2022-2030).  Recent developments in tissue eng
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :